Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection

Tedizolid phosphate is approved for the treatment of acute bacterial skin and skin structure infection (ABSSSI) caused by Gram-positive bacteria in the United States, Europe, and other countries. In this multicenter, double-blind, phase 3 study, 598 adult ABSSSI patients in China, Taiwan, the Philip...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Xiaoju, Alder, Jeff, Li, Li, O’Riordan, William, Rybak, Michael J., Ye, Hui, Zhang, Ruiping, Zhang, Zhongqi, Zhu, Xu, Wilcox, Mark H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591607/
https://www.ncbi.nlm.nih.gov/pubmed/30988146
http://dx.doi.org/10.1128/AAC.02252-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591607/
https://www.ncbi.nlm.nih.gov/pubmed/30988146
http://dx.doi.org/10.1128/AAC.02252-18

Ejemplares similares